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Abstract
Obsessive–compulsive disorder (OCD) and autism spectrum disorders (ASD) commonly co-occur and are considered chal-
lenging to manage when they co-occur in youth. However, clinical characteristics and prognosis of this group remain poorly 
understood. This study examined the prevalence, clinical correlates and outcomes of paediatric OCD co-occurring with 
ASD (OCD + ASD) in a large clinical cohort. Data were extracted from electronic clinical records of young people aged 
4–17 years who had attended a mental health trust in South London, United Kingdom. We identified young people with 
diagnoses of OCD + ASD (n = 335), OCD without ASD (n = 1010), and ASD without OCD (n = 6577). 25% of youth with 
OCD had a diagnosis of ASD, while 5% of those with ASD had a diagnosis of OCD. At diagnosis, youth with OCD + ASD 
had lower psychosocial functioning scores on the clinician-rated Child Global Assessment Scale (CGAS) compared to those 
with either OCD or ASD. Youth with OCD + ASD were equally likely to receive CBT compared to those with OCD but were 
more likely to be prescribed medication and use services for longer than either comparison group. Youth with OCD + ASD 
showed significant improvements in functioning (CGAS scores) after service utilisation but their gains were smaller than 
those with OCD. OCD + ASD commonly co-occur, conferring substantial impairment, although OCD may be underdiagnosed 
in youth with ASD. Young people with co-occurring OCD + ASD can make significant improvements in functioning with 
routine clinical care but are likely to remain more impaired than typically developing youth with OCD, indicating a need for 
longer-term support for these young people.
Keywords Obsessive–compulsive disorder · Autism spectrum disorders · Comorbidity · Treatment outcomes · Psychosocial 
functioning
Introduction
Obsessive–compulsive disorder (OCD) and autism spec-
trum disorder (ASD) are both debilitating conditions in 
young people but are widely viewed as being particularly 
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challenging to manage when they co-occur. ASD in young 
people is associated with high rates of mental health con-
ditions [1], with anxiety and phobic disorders estimated 
in 41% of young people with ASD [2]. It is estimated that 
17–37% of young people with ASD also experience OCD 
symptoms [3, 4] although the proportion of youth with OCD 
who also meet diagnostic criteria for ASD is less clear. Sev-
eral studies have suggested that young people with OCD 
and co-occurring ASD (hereafter referred to as OCD + ASD) 
have clinically distinct psychopathology and impairment 
compared to those with ASD or OCD only [5–7]. However, 
these study findings may lack generalisability as they are 
limited by small sample sizes and selective recruitment, for 
example, excluding youth with intellectual disabilities.
A robust evidence-base supports the efficacy of cogni-
tive behaviour therapy (CBT) and selective serotonin reup-
take inhibitors (SSRIs) in the treatment of paediatric OCD 
[8]. Further, there is early evidence that CBT for children 
and adolescents with ASD is efficacious in the reduction of 
anxiety symptoms including OCD [9, 10], as well as OCD 
specific symptoms [11, 12], although there is indication that 
these treatments may be underutilised in routine clinical care 
[13]. It remains unclear whether youth with OCD + ASD are 
being offered these recommended first-line treatments, and 
if so, whether their outcomes are comparable to typically 
developing youth with OCD. Previous research has shown 
that CBT is associated with a smaller reduction in OCD 
symptoms among those with co-occurring ASD compared 
to typically developing youth [11], but global functional 
outcomes of youth with OCD + ASD following routine 
clinical care is unknown. Combined, this study may pro-
vide insight into diagnostic and treatment practices for youth 
with OCD + ASD during routine clinical care, which has 
important implications for understanding detection, diagno-
sis and provision of support for this population. Further, this 
may provide crucial information for planning and delivering 
mental health services for youth with co-occurring OCD 
and ASD.
In summary, the lack of available information on preva-
lence in a clinical setting, clinical characteristics, treat-
ment provision and functional outcomes of youth with 
OCD + ASD has made it difficult for service providers to 
plan and deliver adequate treatment resources to meet the 
needs of these young people and their families. The cur-
rent study utilised clinical data from a large cohort of young 
people accessing child and adolescent mental health ser-
vices (CAMHS) in the United Kingdom (UK) to address 
substantial gaps in the current literature. Specifically, we 
aimed to examine: (a) the rates of co-occurrence between 
OCD and ASD; (b) the clinical characteristics of youth 
with OCD + ASD; and (c) the treatment received by youth 
with OCD + ASD and their outcomes following service 
utilisation.
Method
Study setting
The study employed a retrospective open cohort design. 
The cohort comprised patients assessed within South Lon-
don and Maudsley NHS Foundation Trust (SLaM) between 
1st January 2007 and 31st December 2016. SLaM provides 
mental health services to young people resident in four 
South London boroughs (Croydon, Lambeth, Lewisham 
and Southwark). In addition, the national and specialist 
services for OCD and ASD accept referrals from across 
the UK. Broadly, CAMHS accept referrals for school age 
children (4–18 years; exceptional cases are accepted below 
this age) with neurodevelopmental disorders, and/or dis-
playing emotional or behavioural difficulties. Youth are 
referred from primary care and child health, educational 
and social care services. All referrals are assessed within 
multidisciplinary teams and assigned diagnoses based on 
ICD-10 [14] criteria. A number of core assessments are 
completed for all patients including clinician ratings of 
global functional impairment. Diagnosis-specific meas-
ures are completed as indicated. SLaM CAMHS provides 
a range of treatments, including pharmacotherapy and psy-
chological therapies.
Data were extracted from anonymised electronic patient 
records using the Clinical Record Interactive Search 
(CRIS) system [15, 16]. This system enables researchers to 
search anonymised records of over 250,000 service users, 
including over 35,000 child and adolescent patients [17], 
representing nearly all those who have been in contact 
with SLaM services since 2006.
Sample
All cases who presented to SLaM services aged between 4 
and 17 years were screened for ICD-10 diagnoses within 
clinician-recorded structured or free-text fields. Those 
with structured data recorded were included if they had 
at least one diagnosis of OCD (F42.0–F42.9) and/or ASD 
(F84.0–F84.9). Diagnostic status was primarily deter-
mined by extracting information from the diagnosis field 
in patient records. Missing structured diagnostic data was 
supplemented by a dedicated natural language processing 
(NLP) application deployed through GATE (Generalized 
Architecture for Text Engineering), which automatically 
codes ‘free-text’ diagnostic data from clinical text in cor-
respondence and progress notes, as previously described 
[16, 18]. Briefly, the GATE application used a preselected 
list of diagnostic terms (‘Autism; Autistic; Autism Spec-
trum Disorder; Autistic Spectrum Disorder; Asperger’s; 
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Pervasive Developmental Disorder; PDD’; ‘Obsessive 
Compulsive Disorder; Obsessive comps; OCD, Obses-
sive–Compulsive’), and used a rule-based algorithm to 
identify diagnostic terms within free-text fields (e.g. pro-
gress notes, correspondence, reports). The NLP applica-
tion contextualises positive diagnoses including identify-
ing whether the diagnosis was: a) confirmed by a clinician 
(coded as positive diagnosis); b) a potential differential 
diagnosis (coded as absent diagnosis); c) relating to a third 
person (coded as absent diagnosis). Details of a similar, 
validated diagnostic extraction method have been reported 
elsewhere [19].
The final sample comprised 7922 young people who 
were categorised into the three diagnostic groups as fol-
lows: OCD + ASD (n = 335), OCD (single diagnosis or any 
co-occurring diagnosis excluding ASD, n = 1010), or ASD 
(single diagnosis or any co-occurring diagnosis excluding 
OCD, n = 6577). ASD and OCD diagnoses were recorded at 
any point that the diagnosis appeared in the patient record, 
within the observational period. For each participant, the 
‘point of diagnosis’ was defined as the first recorded OCD 
diagnosis for the OCD and OCD + ASD groups, and first 
recorded ASD diagnosis for the ASD group. The ‘follow-
up point’ was defined as the end of the observation period, 
which could have been completion of treatment, turning 
18 years old, or death.
Measures
Child Global Assessment Scale (CGAS) The CGAS [20] is 
a clinician-rated measure of global functioning, clinicians 
completing CGAS assessments were from a range of pro-
fessional backgrounds (e.g. psychiatrists, clinical psycholo-
gists and nurses). Ratings are assigned based on the patient’s 
level of emotional and behavioural functioning over the 
previous 3 months, excluding physical impairments. Scores 
range from 1 to 100, with 70 and above indicating norma-
tive functioning. CGAS scores were extracted at diagnosis 
and at the closest point to the end of the observation period 
(follow-up).
Demographics Age was calculated as the difference 
between date of birth and diagnosis date. Socioeconomic 
status was assessed using UK Census data which provided 
‘small level’ (on average 400 households) deprivation scores 
[21], where a higher score equates to greater area depri-
vation. 14 ethnicity categories were collapsed into four to 
improve statistical sensitivity in line with previous research 
using CRIS [15].
Revised Children’s Anxiety and Depression Scale 
(RCADS) The RCADS [22] is a self-report measure of anxi-
ety and depression. The RCADS has strong psychometric 
properties and has been validated for use with children with 
ASD [23, 24]. The OCD subscale includes three questions 
relating to obsessions (e.g. ‘I can’t seem to get bad or silly 
thoughts out of my head’) and three relating to compulsions 
(e.g. ‘I have to keep checking that I have done things right’). 
Items are rated on a 4-point Likert-type scale (‘never’ to 
‘always’) with total scores ranging from 0 to 18. The OCD 
subscale has good psychometric properties in clinical pop-
ulations, with high convergent validity against the OCD 
subscale of the Revised Children’s Manifest Anxiety Scale 
(r = 0.59, p < 0.01), good internal reliability (α = 0.82), and 
an acceptable test–retest coefficient (0.65) [25, 26]. OCD 
symptoms were measured at diagnosis.
The RCADS total score and subscales are reported as fol-
lows: separation anxiety; panic; depression; social anxiety; 
generalised anxiety. The subscales have good internal reli-
ability (αs = 0.71–0.83) and good test–retest coefficients in 
clinical populations (0.75–0.80) [25, 26]. Total and subscale 
scores were measured at diagnosis.
Intellectual disability status Multiaxial ICD-10 Axis 
II diagnosis of Intellectual Disability (F70.x–F73.x) was 
extracted from structured data fields and collapsed into a 
binary variable (i.e. present or absent).
Co-occurring psychiatric diagnosis Multiaxial ICD-10 
Axis II diagnoses were extracted from structured data fields 
and recorded as a binary variable (i.e. present or absent). 
These included any of the following disorders: affective 
(f3); phobic (f40); anxiety (f41); hyperkinetic (f90); con-
duct (f91); mixed conduct and emotion (f92); emotion (f93); 
tic (f95).
National specialist CAMHS A proportion was generated 
comparing young people in national specialist CAMHS 
compared to those in community CAMHS services.
Treatment Provision of CBT and pharmacotherapy [anti-
depressant; antipsychotic; sedative (hypnotic and anxiolytic 
e.g. benzodiazepine)] within 12 months of diagnosis was 
extracted from structured data fields, supplemented with 
free-text searches of correspondence and progress notes 
using NLP application.
Time spent in services We calculated the total number 
of days between diagnosis assessment and the end of the 
observation period (follow-up).
Statistical analysis
All analyses were performed using Stata version 12.0 [27]. 
Two sets of group comparison analyses (t tests and chi-
square tests) were conducted in which the OCD + ASD 
group was compared to: (a) the OCD group; and (b) the 
ASD group. All variables were assessed against test assump-
tions as appropriate. A mixed-model repeated measures 
ANCOVA was used to test the effects of diagnostic group 
(between-subjects factor) and timepoint (within-subjects 
factor: diagnosis versus follow-up). Covariates included 
age, sex, intellectual disability, area deprivation, treatment 
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(pharmacotherapy and CBT), and time lapse between diag-
nosis and follow-up (days). ANCOVA results were explored 
using post-hoc Bonferroni corrected t tests.
Results
Rates of co‑occurrence
Of the total sample (n = 7922), 335 youth (4.2%, 95% CI: 
3.8–4.7) had a co-occurring diagnosis of OCD + ASD. Of 
the 6912 youth with a diagnosis of ASD, 335 (4.8% [95% CI: 
4.4–5.4]) also had a diagnosis of OCD. Of the 1345 youth 
with a diagnosis of OCD, 335 (24.9% [95% CI: 22.6–27.3]) 
also had a diagnosis of ASD.
Demographic and clinical characteristics 
at diagnosis
As shown in Table 1, the mean age of OCD diagnosis was 
significantly younger in the OCD + ASD group (13 years 
6 months) than in the OCD group (14 years). The age of 
ASD diagnosis was significantly older in the OCD + ASD 
group (13 years 4 months) compared to the ASD group 
Table 1  Demographic and clinical characteristics of youth with OCD + ASD, OCD and ASD at diagnosis
CGAS score adjusted for age, sex, intellectual disability, area deprivation, treatment (pharmacotherapy and cognitive behavioural therapy), time 
between assessments
OCD obsessive–compulsive disorder, ASD autism spectrum disorder, CGAS Child Global Assessment Scale, RCADS Revised Children’s Anxi-
ety and Depression Scale, ns non-significant
***p < 0.001; **p < 0.01; *p < 0.05
a First recorded diagnosis
b Expected N based on ethnic composition of local population obtained from UK Census data
OCD + ASD OCD ASD
N = 335 N = 1010 N = 6577
OCD + ASD compared 
to OCD group
OCD + ASD compared 
to ASD group
Mean SD Mean SD t p d Mean SD t p d
 Age at ASD  diagnosisa 13.28 3.01 – – – – – 10.76 3.72 12.16 *** 0.74
 Age at OCD  diagnosisa 13.47 2.81 14.00 2.59 − 3.19 ** 0.20 – – – – –
 Area deprivation 20.88 12.75 22.36 12.44 − 1.85 ns 0.18 27.11 12.15 − 9.02 *** 0.50
 CGAS score 44.30 3.29 49.06 15.57 − 5.35 *** 0.42 48.87 14.60 − 5.66 *** 0.45
RCADS scores
 Total 49.44 31.23 56.68 30.90 − 1.32 ns 0.23 49.68 28.44 − 0.05 ns 0.01
 OCD 7.48 5.29 9.30 5.26 − 2.05 * 0.35 5.72 4.19 2.68 ** 0.37
 Separation anxiety 11.11 8.25 11.81 7.32 − 0.53 ns 0.01 12.04 7.16 − 0.82 ns 0.12
 Panic 8.27 7.50 8.42 6.63 − 0.13 ns 0.02 7.28 6.45 0.97 ns 0.14
 Depression 12.28 6.56 11.42 7.50 0.71 ns 0.12 11.86 7.04 0.39 ns 0.06
 Social anxiety 5.34 4.71 6.49 5.10 − 1.34 ns 0.23 5.93 4.77 − 0.78 ns 0.12
 Generalised anxiety 7.47 5.29 8.89 5.46 − 1.54 ns 0.26 7.34 4.79 0.17 ns 0.03
OCD + ASD compared 
to OCD group
OCD + ASD compared 
to ASD group
N Percent N Percent chi2 p OR N Percent chi2 p OR
Intellectual disability 29 9 11 1 49.93 *** 8.61 1302 20 25.44 *** 0.38
Sex (male) 214 64 488 49 24.42 *** 1.89 4952 76 21.99 *** 0.58
Other psychiatric diagnosis 77 23 247 25 0.30 ns 0.92 834 13 29.58 *** 2.06
Ethnicity N Percent Expected Nb N Percent Expected Nb N Percent Expected Nb
White British 234 73 180.5 656 70 532.5 3070 54 3247
Black 13 3 68.4 71 8 201.8 1417 25 1230.7
Asian 20 6 42.8 46 5 42.8 252 4 260.7
Other 52 16 163.9 168 18 163.9 999 17 999.5
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(10 years 9 months). The greatest prevalence of intellectual 
disability was observed in the ASD group (20%), followed 
by OCD + ASD group (9%), whilst the OCD group had the 
lowest prevalence (1%). The prevalence of any other co-
occurring psychiatric diagnosis for the OCD + ASD group 
was 23%. There was no significant difference in the preva-
lence compared to the OCD group. However, the odds of 
youth in the OCD + ASD group having at least one other 
co-occurring diagnosis was 2.06 times greater than those 
in the ASD group. The OCD + ASD group had the high-
est proportion of White British children (73%), followed 
by the OCD group (70%) and then the ASD group (54%). 
Black children were overrepresented in the ASD group 
compared to expected frequencies in the sampled popula-
tion and underrepresented in the OCD + ASD and OCD 
groups. At diagnosis, young people in the OCD + ASD 
group presented with significantly greater RCADS OCD 
symptom scores (M = 7.48) compared to those with ASD 
(M = 5.72), but significantly lower OCD symptom scores 
compared to those with OCD (M = 9.30). No differences 
were identified between the groups for any other RCADS 
subscales scores or total score. At diagnosis, youth with 
OCD + ASD presented with greater functional impair-
ment as indicated by significantly lower CGAS scores 
(M = 44.30) compared to those with OCD (M = 49.06) and 
ASD (M = 48.87).
Treatment received and clinical outcomes
As shown in Table 2, the OCD + ASD group were engaged 
with services for a mean of 632 days, which was signifi-
cantly longer than the OCD (441  days) or ASD group 
(484 days). 68% of young people in the OCD + ASD group 
were in national specialist CAMHS, compared to 49% in 
the OCD group and 28% from the ASD group. A higher 
proportion of the OCD + ASD group were prescribed antide-
pressant, antipsychotic and sedative medications compared 
to the OCD and ASD groups. The odds of young people 
with OCD + ASD being prescribed antidepressants was 
11 times greater than those with ASD (OR = 11.28) and 
2.5 times greater than those with OCD (OR = 2.57). The 
odds of young people with OCD + ASD being prescribed 
antipsychotics was almost 3 times greater than those with 
ASD (OR = 2.74) and those with OCD (OR = 2.87), and for 
sedatives, the odds were 1.5 times greater for young peo-
ple with OCD + ASD than those with ASD (OR = 1.43) 
and three times greater than those with OCD (OR = 2.99). 
The OCD + ASD group were equally likely to receive CBT 
compared to the OCD group, but more likely than the ASD 
group.
Functional impairment scores at follow-up and their 
change from diagnosis to follow-up are shown in Table 2 
and Fig. 1. A mixed-model ANCOVA (Table 3) was con-
ducted to determine the effect of timepoint (diagnosis versus 
Table 2  Treatment received and outcomes for youth with OCD + ASD, OCD and ASD
CGAS score adjusted for age, sex, intellectual disability, area deprivation, treatment (pharmacotherapy and cognitive behavioural therapy), time 
between assessments
OCD obsessive–compulsive disorder, ASD autism spectrum disorder, CGAS Child Global Assessment Scale, ns non-significant
***p < 0.001; **p < 0.01; *p < 0.05
OCD + ASD OCD ASD
N = 335 N = 1010 N = 6577
OCD + ASD compared 
to OCD group
OCD + ASD compared 
to ASD group
Mean SD Mean SD t p d Mean SD t p d
Time in services (days) 631.71 597.68 441.42 432.61 5.77 *** 0.37 484.37 648.75 3.76 *** 0.24
CGAS at follow-up 54.20 15.01 61.36 16.21 − 7.68 *** 0.46 53.54 16.22 0.77 * 0.04
CGAS change score 8.84 18.30 12.03 16.84 − 3.49 *** 0.18 5.62 17.03 3.79 *** 0.18
OCD + ASD compared 
to OCD group
OCD + ASD compared 
to ASD group
N Percent N Percent chi2 p OR N Percent chi2 p OR
National Specialist 
CAMHS
199 59 500 49 9.87 ** 1.49 1860 28 147.63 *** 3.71
Antidepressant 227 68 454 45 52.37 *** 2.57 1033 16 579.47 *** 11.28
Antipsychotic 117 35 159 16 56.76 *** 2.87 1076 16 76.93 *** 2.74
Sedative 91 27 112 11 50.73 *** 2.99 1363 21 7.96 ** 1.43
CBT 161 48 531 53 2.05 ns 0.83 484 8 624.11 *** 11.65
 European Child & Adolescent Psychiatry
1 3
follow-up), diagnostic group (OCD + ASD versus OCD ver-
sus ASD), and their interaction on functional impairment. 
Analyses controlled for age, sex, intellectual disability, area 
deprivation, treatment (pharmacotherapy and CBT), and 
time lapse between diagnosis and follow-up (days). The 
ANCOVA revealed a main effect of group (F(2,14) = 255.44, 
p < 0.001), indicating that functional impairment scores were 
significantly different between the groups. There was also a 
main effect of timepoint (F(1,14) = 422.68, p < 0.001), show-
ing a significant improvement in psychosocial functioning 
after utilising CAMHS care. Importantly, there was also a 
significant group × timepoint interaction (F(2,14) = 65.36, 
p < 0.001), showing that the extent to which functional 
impairment improved differed between the groups. Post 
hoc t tests were used to decompose these interaction effects 
(see Table 2). The OCD + ASD group showed a significantly 
smaller improvement in functioning (M = 8.84) compared 
to the OCD group (M = 12.03), but a greater improvement 
than the ASD group (M = 5.62). At follow-up, youth with 
OCD + ASD had greater functional impairment (M = 54.20) 
than those with OCD (M = 61.36), but a comparable level to 
those with ASD (M = 53.54).
Discussion
In the largest study of co-occurring OCD and ASD to date, 
we found that approximately 25% of young people with 
OCD also had a diagnosis of ASD. To our knowledge, this is 
the first prevalence estimate of ASD in a clinical population 
of youth with OCD. Of note, the high rate of co-occurrence 
observed in this study may partly reflect the inclusion of 
specialist ASD and OCD services which assess and treat 
more complex cases, including those with co-occurring psy-
chiatric diagnoses. Of those young people who had a diagno-
sis of ASD, approximately 5% also had an OCD diagnosis. 
This figure was considerably lower than expected, although 
previous estimates were based on studies that systematically 
screened for OCD in ASD populations [3, 4]. Thus, it is 
possible that OCD is underdiagnosed in youth with ASD 
in routine clinical practice, because either ASD associated 
problems overshadow OCD symptoms, or OCD symptoms 
are viewed as part of ASD themselves.
In relation to our second aim, we found that several 
demographic and clinical features differentiated youth with 
OCD + ASD from those with OCD. Specifically, those with 
OCD + ASD tended to be younger at the point of OCD diag-
nosis, were more likely to be male, and were more likely 
to have an intellectual disability. Youth with OCD + ASD 
were equally likely to have an additional psychiatric diag-
nosis compared to those with OCD, but were more likely to 
have a co-occurring diagnosis than those with ASD alone. 
In the current study, we found lower OCD symptom sever-
ity among youth with OCD + ASD compared to those with 
OCD. This may reflect the fact that OCD symptoms were 
assessed using a self-report measure, and some young peo-
ple with ASD may lack insight into their symptoms and/
or may be less accurate at self-reporting [28], thus artifi-
cially lowering their OCD symptom score. We found that 
functional impairment was significantly greater in youth 
with OCD + ASD relative to those with OCD, consistent 
with previous findings [5]. Importantly, we also found that 
those with OCD + ASD were more impaired than youth with 
ASD. This difference did not appear to be accounted for 
Fig. 1  Means and 95% confidence intervals for functional deficit 
score by group at diagnosis and follow-up, controlling for age, sex, 
intellectual disability, area deprivation, treatment (pharmacotherapy 
and cognitive behavioural therapy), time between assessments. Scores 
range from 1 to 100: > 70 indicates normative functioning
Table 3  Mixed ANCOVA modelling effects of diagnostic group 
(OCD + ASD, OCD versus ASD) and time (diagnosis versus follow-
up) on functional impairments (CGAS score)
OCD obsessive–compulsive disorder, ASD autism spectrum disorder
df F p
Independent variables
 Group 2 61.38 < 0.001
 Time 1 422.68 < 0.001
 Group × time 2 65.36 < 0.001
Covariates
 Age 1 20.09 < 0.001
 Sex 1 0.00 0.957
 Area deprivation 1 0.25 0.617
 Intellectual disability 1 1224.65 < 0.001
 Antidepressant 1 118.35 < 0.001
 Antipsychotic 1 315.60 < 0.001
 Sedative 1 24.62 < 0.001
 CBT 1 38.60 < 0.001
 Time difference 1 55.70 < 0.001
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by other symptoms such as anxiety, or the presence of co-
occurring diagnoses, since these were comparable between 
the groups. Thus, our findings suggest that OCD and ASD 
are both impairing in their own right, but there is a cumula-
tive burden of suffering from OCD and ASD together.
With respect to our third aim, we found that youth with 
OCD + ASD were engaged in mental health services for 
significantly longer than those with OCD or ASD only. 
Encouragingly, youth with OCD + ASD were equally likely 
to receive CBT compared to those with OCD only. However, 
it is notable that only half of the children in both groups 
accessed CBT; given that CBT is the recommended first-line 
treatment for paediatric OCD [8]. We found high rates of 
pharmacotherapy use in the OCD + ASD group, with 68% 
being prescribed antidepressant, 35% antipsychotic, and 
27% sedative medication. Young people with OCD + ASD 
were considerably more likely to be prescribed these medi-
cations compared to those with OCD or ASD. This dis-
crepancy is unlikely to be accounted for by OCD severity, 
especially given that youth with OCD + ASD scored lower 
on the measure of OCD symptoms at diagnosis compared 
to those with OCD. It is also unlikely that the presence of 
co-occurring diagnoses drives higher rates of medications, 
as there was no difference in diagnosis rates between the 
OCD + ASD and OCD groups. However, it is possible that 
OCD symptoms have a different impact on youth with ASD 
compared to those without, such as greater agitation or 
insomnia, as well as a greater functional impairment, lead-
ing to increased use of medication.
In this study, we found that psychosocial functioning 
improved significantly for youth with OCD + ASD follow-
ing utilisation of mental health services, but that their func-
tional gains were smaller than youth with OCD only. This 
is in line with previous findings that that OCD is a treatable 
condition but that youth with co-occurring ASD often have 
poorer outcomes than their typically developing counterparts 
[11]. We additionally observed that by follow-up, youth 
with OCD + ASD were no longer more impaired than those 
with ASD only, tentatively suggesting that OCD symptoms 
were successfully treated in the OCD + ASD group, while 
ASD symptomatology remained. However, we are unable 
to directly test this hypothesis as OCD symptom measures 
were not available at follow-up.
The current study has several notable strengths. It is the 
first study to utilise a large, representative clinical cohort 
to simultaneously examine youth with OCD + ASD, OCD 
and ASD. Both of the comparison groups (OCD or ASD) 
were allowed to contain co-occurring diagnoses (excluding 
the other diagnosis of interest), meaning that our findings 
are more generalisable to typical clinical settings. Simi-
larly, this study did not exclude participants on the basis of 
intellectual disability, making the results generalisable to 
the wider ASD population. Nevertheless, our results should 
also be considered in the context of some limitations. We 
did not have detailed information regarding medication 
dose or duration, or CBT focus or duration. Furthermore, as 
treatment information was limited to CBT and prescribed 
medications, it is possible that young people with ASD were 
offered a range of psychosocial interventions which were 
not captured in this study. Given that the primary outcome 
measure was a clinician-rated global functioning scale, it 
would be desirable to replicate this study using multiple-
informant measures across a range of functional and symp-
tom domains. Lastly, further research is needed to test 
whether the current findings generalise to other countries 
and healthcare systems.
Implications
Our results have a number of important clinical implica-
tions. Our finding that approximately a quarter of young 
people with OCD also met diagnostic criteria for ASD high-
lights the need for clinicians working with paediatric OCD 
to be have adequate knowledge of ASD. This is important 
to ensure accurate detection, diagnosis and provision of 
support for this population. In the current study, we found 
that a smaller proportion of youth with ASD (5%) had a 
concurrent diagnosis of OCD than expected based on previ-
ous studies in community samples of youth with ASD [3]. 
This finding could suggest that OCD is underdiagnosed in 
young people with ASD in routine clinical practice, pos-
sibly because either ASD associated problems overshadow 
OCD symptoms [2], or OCD symptoms are viewed as part 
of ASD themselves [29]. This emphasizes the importance of 
clinicians being vigilant to OCD symptoms in young people 
with ASD.
Psychosocial functioning was most impaired at diagnosis 
for young people with OCD + ASD compared to those with 
either OCD or ASD, suggesting a cumulative burden of suf-
fering OCD concurrent with ASD. However, functioning not 
only improved after accessing mental health services, but by 
follow-up, young people with OCD + ASD were no longer 
more functionally impaired than those with ASD. These 
findings highlight the value of youth with OCD + ASD 
accessing mental health services, and therefore the impor-
tance of appropriate referral. However, we identified that 
only half of young people with OCD (as a primary diagnosis 
or concurrent with ASD) accessed CBT. As CBT is indi-
cated for first-line treatment for paediatric OCD, this finding 
highlights the need for increased CBT dissemination efforts 
within clinical practice.
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